Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Complete Genomics, Inc. v. Illumina, Inc.
Case Number:
1:19-cv-00970
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 22, 2022
The Top Patent Damages Awards Of 2022
Patent owners won relatively modest damages awards in their infringement battles in 2022, marking a departure from the massive verdicts and judgments handed down by juries and judges over the previous two years.
-
July 14, 2022
Illumina Pays Complete Genomics $325M To End DNA IP Row
After a Delaware federal jury determined Illumina willfully infringed DNA sequencing patents held by Complete Genomics Inc. and owes $334 million — a figure that could be tripled — CGI's Chinese parent MGI said Thursday its rival agreed to pay $325 million to resolve the parties' fights in California and the First State.
-
June 03, 2022
Illumina Wants 'Indefensible' $334M DNA IP Verdict Tossed
Illumina urged a Delaware federal judge Friday to overturn a verdict last month finding that the biotechnology company willfully infringed two Complete Genomics Inc. DNA sequencing patents and owes $334 million in damages, saying the evidence doesn't back the jury's liability finding and the size of the damage award is "indefensible."
-
May 06, 2022
Illumina Told To Pay $334M In DNA Sequencing Patent Trial
A Delaware federal jury decided Friday that Illumina willfully infringed two Complete Genomics Inc. DNA sequencing patents and should pay $334 million in damages, while also invalidating three Illumina patents that CGI was accused of infringing in counterclaims.
-
April 21, 2022
IP Forecast: 6th Circ. To Eye Seed Biz's $7M Trade Secret Win
The Sixth Circuit will consider next week whether certain information on broccoli seeds can fall under trade secrets law when it hears the appeal of a dietary supplements brand that was ordered to pay a seed company more than $9 million after recruiting the outfit's research director. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.